Geographic Atrophy
📧 Sign up to get email alerts when something new happens for Geographic Atrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-29Clinical Trial Results: Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration [NA]
Clinical trial results for retinal fundus flavoprotein fluorescence in geographic atrophy and age-related macular degeneration have been com…
-
CLINICAL_TRIALS trial_result · 2026-06-15Clinical Trial Results: COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy [NA]
A completed clinical trial comparing two ultrawide field imaging systems (Clarus and Optos) for geographic atrophy in age-related macular de…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy [Phase 3]
An open-label extension of avacincaptad pegol in geographic atrophy has completed Phase 3, with results posted on April 14, 2026. The study …
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of RO7669330 in geographic atrophy due…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration
This clinical trial update notes that the National Eye Institute-sponsored study on the natural history of geographic atrophy in age-related…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) [Phase 2]
A Phase 2 trial evaluating intravitreal JNJ-81201887 (AAVCAGsCD59) versus sham for geographic atrophy due to age-related macular degeneratio…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Subtenon PRP Injection for Geographic Atrophy in Dry Age-Related Macular Degeneration [NA]
This entry notes the completion of a clinical trial evaluating subtenon platelet-rich plasma (PRP) injections for geographic atrophy in dry …
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy [Phase 2]
A Phase 2 study is evaluating different doses of BI 1584862 for geographic atrophy, a form of age-related macular degeneration; the trial is…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration [Phase 1, Phase 2]
An update on the ABBV-6628 intravitreal study in adults with geographic atrophy due to age-related macular degeneration, focusing on adverse…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Long-Term Analysis of DImethyl Fumarate, to Slow the Growth of Areas of Geographic Atrophy [Phase 2]
Phase 2 clinical trial update on dimethyl fumarate to slow geographic atrophy in age-related macular degeneration; the study is currently re…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy [Phase 1, Phase 2]
A clinical trial update indicates Kamuvudine-8 is being evaluated for Geographic Atrophy in Phase 1/2 and the study is currently active but …
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe [Phase 3]
A Phase 3 trial evaluating pegcetacoplan (Syfovre) in a prefilled syringe for geographic atrophy secondary to age-related macular degenerati…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Geographic Atrophy (GA) [Phase 3]
A Phase 3 trial evaluating intravitreal vonaprument for geographic atrophy is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD [Phase 3]
An extension study evaluating the long-term safety and efficacy of pegcetacoplan (APL-2) in geographic atrophy due to age-related macular de…
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: Phase 2/3 Study of ALK-001 in Geographic Atrophy [Phase 2, Phase 3]
A Phase 2/3 study of ALK-001 in Geographic Atrophy has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration [Phase 1, Phase 2]
Update on the VOY-101 trial for advanced non-neovascular age-related macular degeneration (geographic atrophy), a Phase 1/Phase 2 study that…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration [Phase 2]
A Phase 2 study of Danicopan for geographic atrophy due to age-related macular degeneration was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD [Phase 1, Phase 2]
The FOCUS study (GT005) in dry age-related macular degeneration was terminated in Phase 1/2, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration [NA]
A completed clinical trial evaluated retinal fundus flavoprotein fluorescence in age-related macular degeneration, including geographic atro…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Study of NGM621 in Participants With Geographic Atrophy [Phase 2]
Phase 2 study of NGM621 for geographic atrophy has completed with results posted on 2025-07-01.
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy [NA]
A completed clinical trial comparing Clarus and Optos ultrawide-field imaging systems for geographic atrophy in age-related macular degenera…
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: Patients With Geographic Atrophy and Their Patient Journey in the United States (US)
A completed US clinical trial examining the patient journey for geographic atrophy, with results posted in May 2025.
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD). [Phase 2]
A Phase 2 trial evaluating oral CT1812 in geographic atrophy secondary to dry age-related macular degeneration has been terminated; no effic…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) [Phase 2]
Phase 2 study to assess safety and efficacy of multiple doses of IONIS-FB-LRx in geographic atrophy due to age-related macular degeneration;…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: The GA in HSI Study
A completed clinical trial update from Optina Diagnostics for the GA in HSI study investigating geographic atrophy. The listed condition is …